Table 4.
Treatment of 67 patients with COVID-19
| Treatment | All patients (n = 67) | Common patients (n = 64) | Severe patients (n = 3) |
|---|---|---|---|
| Oxygen therapy | 41 (61.2) | 39 (60.9) | 3 (100) |
| Mechanical ventilation | 0 | 0 | 0 |
| CRRT | 0 | 0 | 0 |
| ECMO | 0 | 0 | 0 |
| Antibiotics | 8 (11.9) | 7 (10.9) | 1 (33.3) |
| Antifungals | 0 | 0 | 0 |
| Antiviral drug | |||
| KALETRA (Lopinavir / Ritonavir) | 62 (92.5) | 59 (92.2) | 3 (100) |
| Umifenovir | 48 (71.6) | 46 (71.8) | 2 (66.7) |
| Aerosolized α interferon | 66 (98.5) | 63 (98.4) | 3 (100) |
| Oseltamivir | 1 (1.5) | 1 (1.6) | 0 |
| Glucocorticoid therapy | 2 (3.0) | 0 | 2 (66.7) |
Data are expressed as number (%)
Abbreviation: CRRT Continuous Renal Replacement Therapies, ECMO Extracorporeal membrane oxygenation